Private Capital Group’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-6
Closed 2154
2022
Q1
$0 Hold
6
﹤0.01% 2231
2021
Q4
$0 Hold
6
﹤0.01% 2209
2021
Q3
$0 Hold
6
﹤0.01% 2220
2021
Q2
$0 Hold
6
﹤0.01% 2193
2021
Q1
$0 Hold
6
﹤0.01% 2200
2020
Q4
$0 Hold
6
﹤0.01% 2152
2020
Q3
$0 Hold
6
﹤0.01% 2130
2020
Q2
$0 Hold
6
﹤0.01% 2168
2020
Q1
$0 Hold
6
﹤0.01% 2168
2019
Q4
$0 Hold
6
﹤0.01% 2222
2019
Q3
$0 Hold
6
﹤0.01% 2476
2019
Q2
$0 Hold
6
﹤0.01% 2444
2019
Q1
$0 Hold
6
﹤0.01% 2330
2018
Q4
$0 Hold
6
﹤0.01% 2358
2018
Q3
$0 Hold
6
﹤0.01% 2311
2018
Q2
$0 Hold
6
﹤0.01% 2278
2018
Q1
$0 Sell
6
-585
-99% -$1.81K ﹤0.01% 2204
2017
Q4
$0 Buy
+591
New +$2.53K ﹤0.01% 2094

Other funds holding CDMO

Private Capital Group's CDMO Position: Q2 2022 in Review

Private Capital Group sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q2 2022, closing a stake of 6 shares.

Private Capital Group first reported a position in CDMO in Q4 2017 and held it in 18 quarters. The position peaked at $0 in Q1 2022. 187 funds tracked by Wall St. Rank hold CDMO as of Q2 2022.

  • Private Capital Group reported no remaining Avid Bioservices, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Private Capital Group sold 6 Avid Bioservices, Inc. Common Stock shares in Q2 2022.
  • Private Capital Group first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2017 and held it in 18 quarters.
  • Private Capital Group's Avid Bioservices, Inc. Common Stock position peaked at $0 in Q1 2022.
  • 187 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.